Xyrem for Treatment Refractory Insomnia Due to PTSD

Trial Profile

Xyrem for Treatment Refractory Insomnia Due to PTSD

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 06 Sep 2012

At a glance

  • Drugs Sodium oxybate (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Nov 2006 The expected completion date for this trial is now 1 Sep 2007.
    • 20 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top